Charles David Pauza serves as Executive at Traws Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Charles David Pauza has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 12, 2025 involved receiving (via award) 18,471 shares valued at $0.
Charles David Pauza currently holds 115,971 shares of Traws Pharma, Inc. (TRAW), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles David Pauza has been a net neutral trader of TRAW stock. They have purchased $0 and sold $0 worth of shares.
Charles David Pauza's most recent insider trade was on Dec 12, 2025, when they sold 18,471 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |